» Articles » PMID: 10963787

Action of Metalloproteinases Mutalysin I and II on Several Components of the Hemostatic and Fibrinolytic Systems

Overview
Journal Thromb Res
Date 2000 Aug 30
PMID 10963787
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The zinc endopeptidases mutalysin I (100 kDa) and mutalysin II (22.5 kDa) have been previously isolated from bushmaster (Lachesis muta muta) snake venom. Hemorrhagic activity was observed with as little as 0.5 microg (2000 units/mg) and 17.8 microg (56.2 units/mg) for mutalysin I and II, respectively. Additionally, the proteases hydrolyse the Aalpha>Bbeta chain of fibrinogen without clot formation. The specific fibrinogenolytic activity was estimated as 5. 25 and 16.3 micromol fibrinogen/min/micromol protein for mutalysin I and II, respectively. In vitro, the enzymes act directly on fibrin and are not inhibited by serine proteinase inhibitors (SERPINS). Analysis by SDS-PAGE of fibrin hydrolysis by both enzymes showed that mutalysin II (0.22 microM) completely digested the alpha- and gamma-gamma chains and partially the beta-chain (in 120 min incubation). In contrast, mutalysin I (three fold higher concentration than mutalysin II) hydrolyzed selectively the alpha-chain of fibrin leaving the beta and gamma-gamma chains unaffected. Unlike with the plasminogen activator-based thrombolytic agents (e.g., streptokinase), mutalysins do not activate plasminogen. Neither enzyme had an effect on protein C activation. Mutalysin II does not inhibit platelet aggregation in human PRP induced by collagen or ADP. However, mutalysin I showed a selective inhibitory effect on collagen-induced aggregation of human PRP; it did not affect platelet aggregation with ADP as the agonist. The present investigation demonstrates that both native and EDTA-inactivated mutalysin I dose dependently blocked aggregation of human PRP elicited by 10 microg/mL of collagen with an IC(50) of 180 and 580 nM, respectively. These studies suggest that, in addition to the metalloprotease region of mutalysin I, the disintegrin-like domain also participates in the inhibitory effect. The proteolytic activity of mutalysin II against dimethylcasein and fibrin was completely abolished by alpha2-macroglobulin (alpha2-M). The stoichiometry of inhibition was 1.0 mol of enzyme per mol of alpha2-M. In contrast, the proteolytic effect of mutalysin I against the same substrates was not significantly inhibited by alpha2-M. Therefore, the data explain why mutalysin I contributes significantly not only to local but also to systemic bleeding associated with the observed pathological effects of the venom.

Citing Articles

Qualitative Analysis of Proteins in Two Snake Venoms, Gloydius Blomhoffii and Agkistrodon Acutus.

Ha S, Choi Y, Kwag E, Kim S, Yoo H, Kang I J Pharmacopuncture. 2022; 25(1):52-62.

PMID: 35371588 PMC: 8947974. DOI: 10.3831/KPI.2022.25.1.52.


Action of Varespladib (LY-315920), a Phospholipase A Inhibitor, on the Enzymatic, Coagulant and Haemorrhagic Activities of (South-American Bushmaster) Venom.

Gutierres P, Pereira D, Vieira N, Arantes L, Silva Jr N, Torres-Bonilla K Front Pharmacol. 2022; 12:812295.

PMID: 35095526 PMC: 8790531. DOI: 10.3389/fphar.2021.812295.


Subproteome of venom and preliminary studies on LmrSP-4, a novel snake venom serine proteinase.

Wiezel G, Bordon K, Silva R, Gomes M, Cabral H, Rodrigues V J Venom Anim Toxins Incl Trop Dis. 2019; 25:e147018.

PMID: 31131000 PMC: 6521711. DOI: 10.1590/1678-9199-JVATITD-1470-18.


Proteomic Characterization and Comparison of Malaysian Tropidolaemus wagleri and Cryptelytrops purpureomaculatus Venom Using Shotgun-Proteomics.

Zainal Abidin S, Rajadurai P, Chowdhury M, Ahmad Rusmili M, Othman I, Naidu R Toxins (Basel). 2016; 8(10).

PMID: 27763534 PMC: 5086659. DOI: 10.3390/toxins8100299.


Hemorrhage Caused by Snake Venom Metalloproteinases: A Journey of Discovery and Understanding.

Gutierrez J, Escalante T, Rucavado A, Herrera C Toxins (Basel). 2016; 8(4):93.

PMID: 27023608 PMC: 4848620. DOI: 10.3390/toxins8040093.